The European Commission has adopted the main Horizon Europe work programme for 2026-2027. Several call topics related to personalised medicine are included in the work programme for Cluster Health.
The work programme for Cluster 1 ‘Health’ in Horizon Europe is available here:
In the programme, personalised medicine is highlighted as an important area. Call topics especially related to personalised medicine research and innovation are:
- HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseases
- HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens’ access to healthcare through integrated and personalised approaches
- HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
- HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- HORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicine
- HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- HORIZON-HLTH-2027-03-TOOL-08: Towards Artificial General Intelligence (AGI) for healthcare
- HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
- HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
Further, personalised approached might be funded in further call topics, also in the work programmes of Horizon Europe programme parts other than Cluster ‘Health’.